Increasing evidence showed that the levels of these neurotrophins were significantly reduced in the CNS of MS patients and EAE mice and correlated with the deteriorated neuron damage, which implied that increasing the levels of these neurotrophins and/or maintaining their physiological levels in the CNS might be beneficial for MS [42, 50]. Here, BDNF is linked to myeloid sarcoma.